Detalhe da pesquisa
1.
Proteogenomic Landscape of Breast Cancer Tumorigenesis and Targeted Therapy.
Cell
; 183(5): 1436-1456.e31, 2020 11 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-33212010
2.
Proteogenomic Characterization Reveals Therapeutic Vulnerabilities in Lung Adenocarcinoma.
Cell
; 182(1): 200-225.e35, 2020 07 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-32649874
3.
Integrated Proteogenomic Characterization of Human High-Grade Serous Ovarian Cancer.
Cell
; 166(3): 755-765, 2016 Jul 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-27372738
4.
Mapping the KRAS proteoform landscape in colorectal cancer identifies truncated KRAS4B that decreases MAPK signaling.
J Biol Chem
; 299(1): 102768, 2023 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36470426
5.
Lessons learned: establishing a CLIA-equivalent laboratory for targeted mass spectrometry assays - navigating the transition from research to clinical practice.
Clin Proteomics
; 21(1): 12, 2024 Feb 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-38389054
6.
Deep Proteomics Using Two Dimensional Data Independent Acquisition Mass Spectrometry.
Anal Chem
; 92(6): 4217-4225, 2020 03 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-32058701
7.
Quality Assessments of Long-Term Quantitative Proteomic Analysis of Breast Cancer Xenograft Tissues.
J Proteome Res
; 16(12): 4523-4530, 2017 12 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-29124938
8.
Recommendations for the Generation, Quantification, Storage, and Handling of Peptides Used for Mass Spectrometry-Based Assays.
Clin Chem
; 62(1): 48-69, 2016 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-26719571
9.
Linking cancer genome to proteome: NCI's investment into proteogenomics.
Proteomics
; 14(23-24): 2633-6, 2014 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-25187343
10.
A proposal for validation of antibodies.
Nat Methods
; 13(10): 823-7, 2016 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-27595404
11.
Proteogenomic insights suggest druggable pathways in endometrial carcinoma.
Cancer Cell
; 41(9): 1586-1605.e15, 2023 09 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-37567170
12.
A community standard format for the representation of protein affinity reagents.
Mol Cell Proteomics
; 9(1): 1-10, 2010 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-19674966
13.
Proteogenomic Markers of Chemotherapy Resistance and Response in Triple-Negative Breast Cancer.
Cancer Discov
; 12(11): 2586-2605, 2022 11 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-36001024
14.
Evolution of clinical proteomics and its role in medicine.
J Proteome Res
; 10(1): 66-84, 2011 Jan 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-20715861
15.
Targeted mass spectrometry-based assays enable multiplex quantification of receptor tyrosine kinase, MAP Kinase, and AKT signaling.
Cell Rep Methods
; 1(3)2021 07 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-34671754
16.
Targeted Mass Spectrometry Enables Multiplexed Quantification of Immunomodulatory Proteins in Clinical Biospecimens.
Front Immunol
; 12: 765898, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-34858420
17.
Targeted Mass Spectrometry Enables Quantification of Novel Pharmacodynamic Biomarkers of ATM Kinase Inhibition.
Cancers (Basel)
; 13(15)2021 Jul 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-34359745
18.
Proteogenomic insights into the biology and treatment of HPV-negative head and neck squamous cell carcinoma.
Cancer Cell
; 39(3): 361-379.e16, 2021 03 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-33417831
19.
A synopsis of the 3rd annual Cancer Proteomics Conference.
Expert Rev Proteomics
; 7(6): 815-7, 2010 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-21142883
20.
Analytical validation of protein-based multiplex assays: a workshop report by the NCI-FDA interagency oncology task force on molecular diagnostics.
Clin Chem
; 56(2): 237-43, 2010 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-20007859